申请人:MOCHIDA PHARMACEUTICAL CO., LTD.
公开号:EP0324202A1
公开(公告)日:1989-07-19
New acridinium compounds are provided which comply with formula 1, wherein
A is a divalent organic moiety, such as an alkylene chain,
X is a group which can be transformed together with C-9 of the acridine into a dioxetane by reaction with hydrogen peroxide, such as an aryloxy group,
Y is a counter ion, and
Z is a functional group, such as a carboxyl derivative.
These acridinium compounds are useful as chemiluminogenic labels for both heterogeneous and homogeneous immunoassays.
提供了符合式 1 的新吖啶鎓化合物,其中
A 是二价有机分子,如亚烷基链、
X 是可与吖啶的 C-9 一起通过与过氧化氢反应转化为二氧杂环丁烷的基团,如芳基、
Y 是反离子,以及
Z 是官能团,如羧基衍生物。
这些吖啶鎓化合物可用作化学发光标记,用于异质和均质免疫分析。